Trial Profile
MDs on Botox Utility (MOBILITY)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm; Cerebral palsy; Dystonia; Facial nerve diseases; Hemifacial spasm; Hyperhidrosis; Movement disorders; Muscle spasticity; Strabismus; Torticollis
- Focus Therapeutic Use
- Acronyms MOBILITY
- Sponsors Allergan
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2012 Planned End Date changed from 1 Dec 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.